Skip to main content

Table 2 Associations between the genetic polymorphism and neutropenia for docetaxel treatment in the 69 NSCLC patients

From: Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort

SNP

Genotype

n

Grade 3 or 4 neutropenia, %

p-value

febrile neutropenia, n

p-value

adjusted odds ratioa

p-value

ABCC10 rs2125739

TT

54

87.0%

0.028

11

0.105

 

0.013

TC

15

60.0%

 

0

 

0.16 (0.03–0.68)

 

ABCB1 3435C > T

CC

25

88.0%

0.349

4

1.000

 

0.345

CT + TT

44

77.3%

 

7

 

0.50 (0.12–2.09)

 

ABCB1 2677G > T/A

GG

10

100.0%

0.189

3

0.192

 

–

GT + TT + GA + AA+TA

59

78.0%

 

8

 

–

 

ABCB1 1236C > T

CC

12

75.0%

0.685

0

0.191

 

0.546

CT + TT

57

82.5%

 

11

 

1.60 (0.35–7.31)

 

ABCC2 rs12762549

CC

12

100.0%

0.104

1

0.674

 

–

CG + GG

57

77.2%

 

10

 

–

 

SLCO1B3 rs11045585

GG

54

77.8%

0.270

9

1.000

 

0.185

GA

15

93.3%

 

2

 

4.31 (0.50–37.3)

 
  1. aodds ratio of frequency of grade 3/4 neutropenia adjusted by age and sex in a logistic regression analysis
  2. SNP, single nucleotide polymorphism